Roger Patient
Laboratory Members
- Aldo Ciau-Uitz
- Wenchao Gu
- Arif Kirmizitas
- Jana Koth
- Hannah Long
- Stuart Melklejohn
- Rui Monteiro
- Tessa Peterkin
- Phil Pinheiro
- Jarina Schneider
- Filipa Simoes
- Rachel Stephenson
- Kapil Tuladhar
- Jie Zou
Selected publications
- Noseda Michela, Peterkin Tessa, Simoes Filipa C, Patient Roger, and Schneider Michael D (2011) Cardiopoietic factors: extracellular signals for cardiac lineage commitment. Circ Res, 108(1):129-52.
- Ciau-Uitz Aldo, Pinheiro Philip, Gupta Rajeev, Enver Tariq, and Patient Roger (2010) Tel1/ETV6 specifies blood stem cells through the agency of VEGF signaling. Dev Cell, 18(4):569-78.
- Ciau-Uitz A, Walmsley M, and Patient R (2000) Distinct origins of adult and embryonic blood in Xenopus. Cell, 102(6):787-96.
- Walmsley Maggie, Ciau-Uitz Aldo, and Patient Roger (2002) Adult and embryonic blood and endothelium derive from distinct precursor populations which are differentially programmed by BMP in Xenopus. Development, 129(24):5683-95.
- Peterkin Tessa, Gibson Abigail, and Patient Roger (2003) GATA-6 maintains BMP-4 and Nkx2 expression during cardiomyocyte precursor maturation. EMBO J, 22(16):4260-73.
| Web | Personal Website |
|---|---|
| roger.patient@imm.ox.ac.uk |
Cells
are programmed during embryonic development. As they move through the
embryo, they receive signals from neighbouring cells thereby
establishing their gene expression programmes. The agents of this
programming are transcription factors whose expression is initially
controlled by the embryonic signals and therefore by other
transcription factors. Transcriptional regulatory networks are
established, which become independent of the initiating signals but may
remain dependent on maintenance signalling. Thus, as cells
differentiate and arrive in their niches, their networks become
stabilised. Understanding how these networks are established and
maintained is the main interest of our lab. Our focus is on blood and
the cardiovascular system. We have a particular interest in the
programming of blood stem cells, an understanding of which will inform
our understanding of many diseases including leukaemias. For example,
genetic and environmental insults can be modelled and both the
consequences and actions that might induce recovery can be predicted.
In addition, realising the potential of stem cells to repair damaged or
lost tissue will depend on the ability to manipulate these cells which
in turn will benefit from a better understanding of these molecular
circuitries.
We are studying these processes in amphibia and fish (Xenopus and
zebrafish), whose embryos are laid in large numbers and develop
externally. Techniques have been developed to manipulate signalling
regimes and transcription factor activities in these embryos as they
develop. Methodologies include genetic mutations, antisense depletion,
mRNA injection, transgenesis, dominant negative expression and small
molecule inhibition. The consequences of perturbation for the
expression of large numbers of genes can readily be determined using
automated in situ hybridisation. Cell lineages have been traced
enabling targeted perturbations. In addition, we have the capacity to
study development in embryo explants to simplify development in defined
conditions. In these ways, we are defining how embryos programme blood
and the cardiovascular system, and we are recapitulating these
processes in vitro.

Blood stem cells (purple) emerging in the floor of the dorsal aorta independently of the circulating primitive red cells in zebrafish embryos
